It is also noteworthy that some RUNX1 mutants associated with breast cancer cannot be sumoylated through PIAS1, and that in sumoylation defective mutants of RUNX3 the tumor suppressor capacity is nullified, promoting tumor growth. This evidence concerns the gene PIAS1 and breast cancer.